Irritable bowel syndrome:Epidemiology,overlap disorders,pathophysiology and treatment

作     者：Kai-Yue Huang Feng-Yun Wang Mi Lv Xiang-Xue Ma Xu-Dong Tang Lin Lv 

作者机构：Institute of Digestive DiseasesXiyuan Hospital of China Academy of Chinese Medical SciencesBeijing 100091Chin Institute of Digestive DiseasesBeijing Institute of Spleen and Stomach Disease of Traditional Chinese MedicineBeijing 100091China 

出 版 物：《World Journal of Gastroenterology》 (世界胃肠病学杂志（英文版）)

年 卷 期：2023年第29卷第26期

页      面：4120-4135页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：National Natural Science Foundation of China,No.81873297 the Fundamental Research Funds for the Central Public Welfare Research Institutes,China,No.ZZ13-YQ-006 Innovation Fund of Chinese Academy of Chinese Medical Sciences,China,No.CI2021A01003 

主　　题：Irritable bowel syndrome Overlap Pathophysiology Treatment 

摘      要：Irritable bowel syndrome (IBS) is a common chronic gastrointestinal disease with a significant impact on patients’ quality of life and a high socioeconomic burden. And the understanding of IBS has changed since the release of the Rome Ⅳ diagnosis in 2016. With the upcoming Rome Ⅴ revision, it is necessary to review the results of IBS research in recent years. In this review of IBS, we can highlight future concerns by reviewing the results of IBS research on epidemiology, overlap disorders, pathophysiology, and treatment over the past decade and summarizing the latest research.